About Elizabeth Arden (NASDAQ:RDEN)
Elizabeth Arden, Inc. is a global beauty products company with a portfolio of fragrance, skin care and cosmetics brands. The Company's segments include North America and International. The Company's North America segment sells its portfolio of owned, licensed and distributed brands, including the Elizabeth Arden products, to retailers, mass retailers and distributors in the United States, Canada and Puerto Rico, and also includes its direct to consumer business, which consists of its Elizabeth Arden branded retail outlet stores and its e-commerce business in North America. The Company's North America segment also sells Elizabeth Arden products through the Red Door Spa beauty salons and spas. The Company's International segment sells its portfolio of owned and licensed brands, including its Elizabeth Arden products, to perfumeries, boutiques, department stores, travel retail outlets and distributors in approximately 120 countries outside of North America.
Industry, Sector and Symbol:
- Industry: Cosmetics & Perfumes
- Sub-Industry: Personal Products
- Sector: Cosmetics & Perfumes
- Symbol: NASDAQ:RDEN
- CUSIP: 28660G10
- Web: www.elizabetharden.com
- Debt-to-Equity Ratio: 5.93%
- Current Ratio: 1.59%
- Quick Ratio: 0.69%
- Trailing EPS: ($2.49)
- Net Margins: -11.89%
- Return on Equity: -135.03%
- Return on Assets: -11.66%
Frequently Asked Questions for Elizabeth Arden (NASDAQ:RDEN)
What is Elizabeth Arden's stock symbol?
Elizabeth Arden trades on the NASDAQ under the ticker symbol "RDEN."
How were Elizabeth Arden's earnings last quarter?
Elizabeth Arden, Inc. (NASDAQ:RDEN) posted its earnings results on Wednesday, August, 10th. The company reported ($0.58) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.78) by $0.20. The business had revenue of $192.70 million for the quarter, compared to analysts' expectations of $193.75 million. Elizabeth Arden had a negative net margin of 11.89% and a negative return on equity of 135.03%. View Elizabeth Arden's Earnings History.
Who are some of Elizabeth Arden's key competitors?
Some companies that are related to Elizabeth Arden include Apple (AAPL), Alphabet (GOOGL), Alphabet (GOOG), Microsoft Corporation (MSFT), Amazon.com (AMZN), Facebook (FB), Intel Corporation (INTC), Cisco Systems (CSCO), Comcast Corporation (CMCSA), NVIDIA Corporation (NVDA), Amgen (AMGN), Broadcom Limited (AVGO), QUALCOMM Incorporated (QCOM), The Kraft Heinz Company (KHC), Texas Instruments Incorporated (TXN), Gilead Sciences (GILD), PayPal Holdings (PYPL) and Adobe Systems Incorporated (ADBE).
How do I buy Elizabeth Arden stock?
Shares of Elizabeth Arden can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Elizabeth Arden?
Elizabeth Arden's mailing address is 880 Sw 145 Avenue, Suite 200, PEMBROKE PINES, FL 33027, United States. The company can be reached via phone at +1-954-3646900.
MarketBeat Community Rating for Elizabeth Arden (NASDAQ RDEN)MarketBeat's community ratings are surveys of what our community members think about Elizabeth Arden and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for Elizabeth Arden (NASDAQ:RDEN) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Analysts' Consensus Price Target: ||N/A|
Consensus Price Target History for Elizabeth Arden (NASDAQ:RDEN)
Analysts' Ratings History for Elizabeth Arden (NASDAQ:RDEN)
(Data available from 11/19/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|9/25/2016||B. Riley||Reiterated Rating||Neutral||$14.00||N/A|
|6/8/2016||Imperial Capital||Reiterated Rating||Outperform||$14.00||N/A|
Earnings History and Estimates Chart for Elizabeth Arden (NASDAQ:RDEN)
Earnings History by Quarter for Elizabeth Arden (NASDAQ RDEN)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/10/2016||Q416||($0.78)||($0.58)||$193.75 million||$192.70 million||View||Listen|
|5/5/2016||Q316||($0.74)||($0.59)||$190.33 million||$191.90 million||View||N/A|
|2/4/2016||Q216||$0.60||$0.10||$344.58 million||$316.20 million||View||N/A|
|11/4/2015||Q116||($0.17)||($0.18)||$267.88 million||$266.00 million||View||N/A|
|8/6/2015||Q415||($0.65)||($1.57)||$188.70 million||$175.50 million||View||N/A|
|5/7/2015||Q315||($0.47)||($0.86)||$194.48 million||$191.70 million||View||Listen|
|2/5/2015||Q2||$0.62||$0.28||$370.16 million||$333.60 million||View||Listen|
|10/30/2014||Q1||($0.53)||($0.43)||$275.10 million||$270.40 million||View||Listen|
|8/19/2014||Q414||($0.34)||($1.04)||$241.64 million||$191.72 million||View||N/A|
|5/12/2014||Q314||$0.01||($0.84)||$256.85 million||$210.80 million||View||Listen|
|2/5/2014||Q214||$1.08||$1.08||$416.60 million||$418.00 million||View||Listen|
|10/30/2013||Q114||$0.15||$0.22||$342.13 million||$343.60 million||View||Listen|
|8/8/2013||Q4 2013||$0.33||$0.10||$289.86 million||$267.60 million||View||Listen|
|5/2/2013||Q3 2013||$0.02||$0.02||$261.31 million||$264.50 million||View||Listen|
|1/31/2013||Q2 2013||$1.63||$1.58||$492.30 million||$468.00 million||View||Listen|
|11/5/2012||Q113||$0.42||$0.44||$336.26 million||$344.50 million||View||N/A|
Earnings Estimates for Elizabeth Arden (NASDAQ:RDEN)
2017 EPS Consensus Estimate: ($0.80)
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Elizabeth Arden (NASDAQ:RDEN)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Elizabeth Arden (NASDAQ RDEN)
Insider Ownership Percentage: 15.20%
Institutional Ownership Percentage: 70.70%
Insider Trades by Quarter for Elizabeth Arden (NASDAQ RDEN)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|3/3/2016||Eric Lauzat||Insider||Buy||5,000||$6.00||$30,000.00|| |
|12/7/2015||E Scott Beattie||CEO||Sell||27,000||$10.91||$294,570.00|| |
|12/4/2014||Oscar E Marina||EVP||Sell||7,081||$17.28||$122,359.68|| |
|11/24/2014||E Scott Beattie||CEO||Sell||25,000||$18.03||$450,750.00|| |
|10/24/2014||Rhone Capital L.L.C.||Major Shareholder||Buy||19,200||$16.81||$322,752.00|| |
|10/23/2014||Rhone Capital L.L.C.||Major Shareholder||Buy||72,274||$16.97||$1,226,489.78|| |
|10/13/2014||Rhone Capital L.L.C.||Major Shareholder||Buy||120,912||$17.00||$2,055,504.00|| |
|10/7/2014||Rhone Capital L.L.C.||Major Shareholder||Buy||149,443||$16.96||$2,534,553.28|| |
|10/6/2014||Rhone Capital L.L.C.||Major Shareholder||Buy||29,744||$16.98||$505,053.12|| |
|11/27/2013||Joel Ronkin||EVP||Sell||20,000||$39.39||$787,800.00|| |
|11/21/2013||Joel Ronkin||EVP||Sell||1,759||$38.03||$66,894.77|| |
|9/23/2013||Dirk Trappmann||EVP||Sell||7,666||$34.76||$266,470.16|| |
|9/20/2013||Hoy Heise||EVP||Sell||8,000||$35.32||$282,560.00|| |
|8/26/2013||Joel Ronkin||EVP||Sell||3,600||$35.43||$127,548.00|| |
|6/17/2013||Stephen J Smith||CFO||Sell||16,900||$48.00||$811,200.00|| |
|6/5/2013||Hoy Heise||EVP||Sell||8,240||$46.34||$381,841.60|| |
|5/17/2013||Oscar E Marina||EVP||Sell||15,000||$48.63||$729,450.00|| |
|5/8/2013||Pierre Pirard||EVP||Sell||7,134||$44.00||$313,896.00|| |
|8/9/2012||Oscar E Marina||VP||Sell||6,600||$46.25||$305,250.00|| |
|8/9/2012||Richard C W Mauran||Director||Sell||73,675||$46.69||$3,439,885.75|| |
Latest Headlines for Elizabeth Arden (NASDAQ RDEN)
Elizabeth Arden (NASDAQ RDEN) Chart for Sunday, November, 19, 2017